Tag
Fredun Pharmaceuticals Limited
2 articles
Fredun Pharmaceuticals NSE Listing Effective August 17
Fredun Pharmaceuticals equity shares permitted for trading on NSE from August 17, 2026.
Listing follows NSE Circular Ref. No. 1355/2026 dated August 14, 2026.
Company maintains existing BSE listing wi
Fredun Pharmaceuticals Q1 FY27 Revenue Jumps 90%
Fredun Pharmaceuticals reported Q1 FY27 standalone revenue of ₹228.25 crore, a 90.44% YoY growth, with net profit up 94.63% to ₹13.17 crore.
Management outlined a 3-5 year growth trajectory of 30-35%,